Moon Tae Chul, Son So Young, Chang Hyeun Wook
College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Korea.
Biol Pharm Bull. 2007 Sep;30(9):1668-73. doi: 10.1248/bpb.30.1668.
Platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF) acetylhydrolase (PAF-AH) activity has been identified in bovine colostrum and high levels of this activity are found in early colostrum (within 24 h after parturition). In this study, PAF-AH in early colostrum was purified by ammonium sulfate precipitation, and sequential use of butyl-Toyopearl 650M, DEAE-Sepharose, heparin-Sepharose, hydroxyapatite, chelating-Sepharose and Mono Q HPLC column chromatography. This enzyme is a monomeric polypeptide with a molecular weight of approximately 45 kDa on 12.5% SDS-PAGE. The V(max) and K(m) for PAF-AH were 87.6 microM and 7.96 nmol/min/mg respectively. This enzyme was inhibited by phenylmethylsulfonyl fluoride, iodoacetamide and p-bromophenacylbromide, suggesting that both serine and histidine residues are required for enzyme activity. It was not inactivated by NaF or dithiothreitol. The purified enzyme did not degrade phospholipids with a long chain fatty acyl group at the sn-2 position. Accordingly, this enzyme is distinct from phospholipase A(2). In addition, PAF-AH selectively hydrolyzed oxidatively modified phosphatidylcholine. Furthermore, this enzyme was shown by Western blot analysis using antibody to human plasma PAF-AH to be plasma type PAF-AH. These results clearly demonstrate that 45 kDa plasma type PAF-AH activity exists in bovine colostrum.
血小板活化因子(1-O-烷基-2-乙酰基-sn-甘油-3-磷酸胆碱;PAF)乙酰水解酶(PAF-AH)活性已在牛初乳中得到鉴定,且在初乳早期(分娩后24小时内)发现该活性水平较高。在本研究中,通过硫酸铵沉淀以及依次使用丁基-Toyopearl 650M、DEAE-琼脂糖、肝素-琼脂糖、羟基磷灰石、螯合-琼脂糖和Mono Q高效液相色谱柱层析对初乳早期的PAF-AH进行了纯化。在12.5%十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上,该酶是一种分子量约为45 kDa的单体多肽。PAF-AH的V(max)和K(m)分别为87.6微摩尔和7.96纳摩尔/分钟/毫克。该酶受到苯甲基磺酰氟、碘乙酰胺和对溴苯甲酰溴的抑制,这表明丝氨酸和组氨酸残基对于酶活性都是必需的。它不会被氟化钠或二硫苏糖醇灭活。纯化后的酶不会降解在sn-2位带有长链脂肪酰基的磷脂。因此,这种酶与磷脂酶A(2)不同。此外,PAF-AH选择性地水解氧化修饰的磷脂酰胆碱。而且,使用抗人血浆PAF-AH抗体进行的蛋白质印迹分析表明该酶是血浆型PAF-AH。这些结果清楚地表明牛初乳中存在45 kDa血浆型PAF-AH活性。